logo

For the Inventor, By the Inventor

New York, NY, United States of America

Yoshiyuki Fukase

This inventor holds 16 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Heterocyclic Compounds. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2010-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiyuki Fukase. Retrieved from https://idiyas.com/inventor/yoshiyuki-fukase

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 18.8

 

Average Co-Inventor Count = 9.8

ph-index = 4

Forward Citations = 28(Granted Patents)


Location History:

  • Osaka, JP (2010 - 2013)
  • Kanagawa, JP (2015)
  • Fujisawa, JP (2017)
  • New York, NY (US) (2016 - 2023)

Company Filing History:

goldMedal16 out of 1,228 
 
Takeda Pharmaceutical Company Limited
 patents

Years Active: 2010-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Amide Compounds
ROR Inhibitors
Triazole Derivative
ROR Gamma-T
Condensed Heterocyclic
Inhibitory Action
Pharmaceutical Chemistry
Chemical Compounds
Drug Development
Organic Synthesis
Therapeutic Applications
16 patents (USPTO):Explore Patents
1. 11851449 - Heterocyclic amide compounds having an RORvt inhibitory action (2023-12-26),
2. 11053262 - Heterocyclic amide compounds having RORyT inhibitory action (2021-07-06),
3. 10472376 - Amide compound (2019-11-12),
4. 10093629 - Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors (2018-10-09),
5. 10053468 - Heterocyclic compound (2018-08-21),
6. 10000488 - Heterocyclic compound (2018-06-19),
7. 9834520 - Heterocyclic compound (2017-12-05),
8. 9650343 - Heterocyclic compound (2017-05-16),
9. 9630924 - Heterocyclic compound (2017-04-25),
10. 9573903 - Heterocyclic compound (2017-02-21),
11. 9365520 - Heterocyclic compound (2016-06-14),
12. 9156837 - Heterocyclic compound (2015-10-13),
13. 9120776 - Condensed heterocyclic compound (2015-09-01),
14. 8466282 - Heterocyclic compound and use thereof (2013-06-18),
15. 8329691 - Amide compounds and use of the same (2012-12-11),

Title: Innovations of Yoshiyuki Fukase

Introduction

Yoshiyuki Fukase is a prominent inventor based in New York, NY, known for his significant contributions to the field of pharmaceutical sciences. He holds a total of 16 patents, showcasing his innovative spirit and dedication to advancing medical research.

Latest Patents

Fukase's latest patents include "Heterocyclic amide compounds having an RORγt inhibitory action," which relates to compound (I) or a salt thereof that exhibits RORγt inhibitory action. The formula (I) includes symbols defined in the specification. Another notable patent is "Heterocyclic amide compounds having RORγT inhibitory action," which also pertains to compound (I) or a salt thereof with RORγT inhibitory action, with the formula (I) similarly defined.

Career Highlights

Fukase is currently associated with Takeda Pharmaceutical Company Limited, where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in developing new therapeutic compounds that have the potential to improve patient outcomes.

Collaborations

Fukase collaborates with esteemed colleagues such as Satoshi Yamamoto and Junya Shirai, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yoshiyuki Fukase's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…